MAPT and Alzheimer disease: Klein and colleagues used H3K9 acetylation (H3K9ac) as a marker in an epigenome-wide association study to reveal a tau-driven disorganization of chromatin in AD affecting 5990 out of 26,384 H3K9ac domains [119].